You are here

vaccines

GSK's shingles vaccine gets green light from EMA panel

GSK's shingles vaccine gets green light from EMA panel

Reuters

Flag link:

Here Are 2 Possible Steps Towards A Universal Flu Vaccine

Here Are 2 Possible Steps Towards A Universal Flu Vaccine

Forbes

universal flu vaccine

Flag link:

PharmaJet touts needle-free tech for polio vaccine administration

PharmaJet touts needle-free tech for polio vaccine administration

Drug Delivery Business News

PharmaJet Stratis

Flag link:

Astellas, Vical's CMV vaccine comes up short in Phase 3

Astellas, Vical's CMV vaccine comes up short in Phase 3

Biopharma Dive

cytomegalovirus

clinical trials

Flag link:

Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab

Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab

Endpoints

cancer vaccines

Flag link:

JPM18: Novavax investors cheer RSV vaccine update, then pull back

JPM18: Novavax investors cheer RSV vaccine update, then pull back

Biopharma Dive

Flag link:

Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report

Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report

Fierce Pharma

Flag link:

Sanofi’s R&D day poses some big challenges as skeptics circle in wake of a Dengvaxia fiasco

Sanofi’s R&D day poses some big challenges as skeptics circle in wake of a Dengvaxia fiasco

Endpoints

Flag link:

Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines

Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines

Stat

Flag link:

Philippines wants money back from Sanofi for dengue vaccine

Philippines wants money back from Sanofi for dengue vaccine

Yahoo/AP

Flag link:

Severe dengue vaccine risk in uninfected '2 in a 1,000' -Sanofi

Severe dengue vaccine risk in uninfected '2 in a 1,000' -Sanofi

Yahoo/Reuters

Flag link:

Sanofi’s bad, awful, terrible development week ends with PhIII C. diff failure

Sanofi’s bad, awful, terrible development week ends with PhIII C. diff failure

Endpoints

clinical trials

Flag link:

Takeda announces clinical trial for anti-Zika vaccine

Takeda announces clinical trial for anti-Zika vaccine

GoinPharma

clinical trials

Flag link:

J&J-led coalition launches a landmark efficacy study for an HIV mosaic vaccine

J&J-led coalition launches a landmark efficacy study for an HIV mosaic vaccine

Endpoints

HVTN 705/HPX2008

Flag link:

New Sanofi dengue vaccine could worsen disease in some people

New Sanofi dengue vaccine could worsen disease in some people

Stat

Flag link:

Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180

Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180

Fierce Pharma

Flag link:

Takeda pushes U.S.-backed Zika vaccine into the clinic

Takeda pushes U.S.-backed Zika vaccine into the clinic

Fierce Pharma

Flag link:

Merck will delay filing Ebola vaccine for approval until 2018, company confirms

Merck will delay filing Ebola vaccine for approval until 2018, company confirms

Fierce Pharma

Flag link:

HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens

HPV Vaccination Immunity Remains Strong 10 Years Later, Especially For Preteens

Forbes

Flag link:

This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person

This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person

Yahoo/Bloomberg

cancer vaccines

Moderna Therapeutics

personalized medicine

Flag link:

Pages